HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junfeng Peng Selected Research

O-desmethylmethoxyphenamine (ODMP)

1/2022Comparison of early postoperative outcomes between omega-like duct-to-mucosa pancreatojejunostomy and conventional duct-to-mucosa pancreatojejunostomy after pancreaticoduodenectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junfeng Peng Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 01/2019
3Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 10/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Pancreatic Fistula (Pancreatic Fistulas)
01/2022
1Liver Diseases (Liver Disease)
04/2021
1Progressive Bulbar Palsy (Fazio Londe Syndrome)
09/2016
1Stroke (Strokes)
09/2016
1Deglutition Disorders (Dysphagia)
09/2016

Drug/Important Bio-Agent (IBA)

3GoldIBA
12/2021 - 10/2019
2Long Noncoding RNAIBA
03/2021 - 01/2019
1O-desmethylmethoxyphenamine (ODMP)IBA
01/2022
1dimethylbis(sulfinylbis(methane)- S)platinum(II)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1lime (calcium oxide)FDA Link
04/2021
1Messenger RNA (mRNA)IBA
03/2021
1Therapeutic UsesIBA
09/2016

Therapy/Procedure

1Pancreaticoduodenectomy
01/2022